The pulmonary surfactant proteins 000 D) and SP-C (4,000 D) accelerate surface film formation by surfactant phospholipids. We used cDNA probes to examine regulation of these proteins in human fetal lung. The mRNAs were detectable at 13 wk gestation and increased to -50% (SP-B) and -15% (SP-C) of adult levels at 24 wk. The mRNAs were detected only in lung of 11 dog tissues examined. When human fetal lung was cultured as explants without hormones, SP-B mRNA increased and SP-C mRNA decreased. Exposure for 48 h to glucocorticoids, but not other steroids, increased both SP-B mRNA (-4-fold) and SP-C mRNA (-30-fold) vs.
Introduction
Pulmonary surfactant lowers the surface tension within lung alveoli, allowing for normal respiration. In addition to surface active phosphatidylcholine and other phospholipids, surfactant contains at least three proteins that are thought to be important for surfactant structure and function. The surfac-28,000-36,000 D), SP-B (hydrophobic protein of -8,000 D), and SP-C (hydrophobic protein of -4,000 D) (1) . The hydrophobic proteins markedly increase the rate of adsorption of surfactant phospholipids to the air-aqueous interface and appear to be important components of replacement surfactant preparations that are being tested clinically for treatment of hyaline membrane disease in premature infants (1) (2) (3) (4) (5) (6) (7) (8) .
The hydrophobic proteins have recently been purified and their cDNAs sequenced. SP-B arises from a 42,000-D precursor protein that undergoes both amino and carboxy-terminal processing to produce the active peptide (Mr = 18,000 unreduced). SP-C is formed from a precursor protein of - 21 ,000 D and contains an unusual polyvaline domain. The genes for the two proteins are located on different chromosomes in the human (2, 3, (9) (10) (11) (12) .
Maturation of the fetal lung, including the surfactant system, is known to be under hormonal regulation (13). Synthesis of surfactant phosphatidylcholine is increased by glucocorticoids, thyroid hormones, and agents that increase intracellular cAMP. Prenatal glucocorticoid treatment is used to reduce the incidence of hyaline membrane disease in prematurely born infants (13). Recent studies indicate that synthesis of SP-A and its mRNA is also affected by various hormones. Synthesis of SP-A is stimulated by low concentrations of glucocorticoids (and inhibited in human lung by higher concentrations and longer exposures) and by cAMP (14) (15) (16) (17) (18) (19) (20) (21) (22) . There are also reports that SP-A synthesis is stimulated by epidermal growth factor and inhibited by both transforming growth factor-,B and insulin (22, 23) .
In the present study we have examined the developmental and hormonal regulation of the mRNAs for SP-B and SP-C in fetal human lung. We find that there is increasing expression of both genes during the second trimester and that glucocorticoids stimulate expression of both during explant culture. The properties of the induction processes suggest different mechanisms of pretranslational regulation of SP-B and SP-C synthesis. (14) . To assess mRNA size, electrophoresis was done in 1.2% agarose gels in the presence of glyoxal and SDS, and major rRNA bands were visualized with ethidium bromide. RNA was transferred to nitrocellulose paper by blotting and hybridized with 32P-labeled human cDNAs for SP-B and SP-C as described below. To measure mRNA content, specific amounts of RNA (usually 0.5-4 Mg) were applied to nitrocellulose filters for dot blot analysis. Each blot also contained various amounts (0.25-2 Mug) of adult human lung RNA (pooled in equal amounts from four specimens); when probed individually, the adult samples varied by a maximum of 1.5-and 2.1-fold for content of SP-B mRNA and SP-C mRNA, respectively. Hybridization with cytosol of isolated cells was performed by the cytoblot method of White and Bancroft (26) . Hybridization for SP-B and SP-C mRNAs was carried out with 32P-labeled dog or human cDNA probes prepared by nick translation. Each cDNA contains nearly the entire coding sequence for the SP-B or SP-C precursor protein as previously described (2, 3) . In control experiments some blots were reprobed with 32P-labeled cDNA for the a chain of the GTP-binding regulatory protein of adenylate cyclase (GJ) or for actin (27, 28 
Methods

Results
Ontogeny in human lung. The human cDNA probes were used to assess the size of mRNAs for SP-B and SP-C in fetal and adult lung. The mRNA for each protein appeared as a single major band on Northern analysis (Fig. 1) . The Distribution among dog tissues. We studied the tissue distribution of SP-B and SP-C mRNAs using canine cDNA probes. RNA was prepared from 2 specimens oflung and from 10 other newborn dog tissues. SP-C mRNA was detected in lung but not kidney, stomach, liver, thymus, adrenal, heart, intestine, spleen, ovary, or muscle ( Fig. 3 ). When the dot blot was washed and reprobed with cDNA for G.", mRNA was detected in every tissue (data not shown).
In tissues from adult dogs, mRNA for SP-C was present in adult lung tissue at about three times the concentration in newborn lung. Among the same 10 other adult tissues there was no detectable hybridization except for a faint signal with spleen (< 0.3% of the lung value). In similar studies with SP-B cDNA, hybridizable RNA was detected only in lung tissue of both newborn and adult dogs (data not shown).
Effect of culture and glucocorticoids. To examine regulation of SP-B and SP-C mRNAs in vitro, human fetal lung tissue was maintained in explant culture in the presence or absence of dexamethasone (10 nM) or other steroids. The effects ofculture and dexamethasone treatment are summarized in Table I . The content of SP-B mRNA increased during explant culture in the absence ofserum or hormones. In contrast, levels of SP-C mRNA decreased initially (low or undetectable on days 1-3 ofculture), then increased but were still below the preculture level at day 5. Treatment with 10 nM dexamethasone increased the content of SP-B mRNA 2-to 4-fold over control (no hormone) and increased levels of SP-C mRNA by 20-to 30-fold; maximal stimulation occurred on day 3 for both mRNAs. Levels of mRNA for both proteins were also higher after dexamethasone treatment compared with preculture levels. By contrast, there were no consistent effects of culture or dexamethasone treatment on levels of mRNA for actin and G,, (data not shown).
Dexamethasone stimulation was also examined as a function of time of exposure to hormone (Fig. 4) . In these experiments the explants were all cultured for 76 h with addition of 10 nM dexamethasone at various times before harvesting the tissue. Levels of both mRNAs were significantly increased after 10 h exposure to dexamethasone and reached maximal values by 30 h. The time required for half-maximal stimulation under these conditions was somewhat less for SP-B (-14 h) than for SP-C (-19 h). Fig. 5 shows the effect in one experiment (representative of three) of a brief exposure to cortisol. Explants were treated with diluent (control) or cortisol (1 MM) beginning on day 1 of culture. The hormone was removed from some cultures 24 h later (day 2) by changing the culture medium three times at 2-h intervals. Cortisol was chosen for these experiments because of its relatively fast dissociation from glucocorticoid receptors (29) . Removal of cortisol blocked any further increase in SP-C mRNA content and diminished the response for SP-B mRNA; by day 4-5 levels in cultures treated briefly with cortisol were similar to control values. Total RNA (rig) Figure 3 . Dot blot of SP-C mRNA in newborn dog tissues. RNA was prepared from two specimens of lung and from other tissues as shown. Relatively large amounts of RNA were applied to the blot and the film was overexposed to detect low levels of hybridization. We also performed dose-response studies with cortisol (Fig. 6, C and D) . Induction of SP-B mRNA was half maximal at -300 nM and optimal at -1 MM. Half-maximal stimulation of SP-C mRNA occurred at -1 AM and was optimal at 2Io10M.
The effect of various other steroids on induction of SP-B and SP-C mRNAs was determined (Fig. 7) . In these experiments explants were exposed to 1O nM dexamethasone or Effect ofcAMP. We also examined the effect of agents that increase intracellular cAMP. As shown in Table II Levels for both messages were generally less in preculture fetal tissue than in adult lung although there was considerable variability later in the second trimester. Despite the similar in vivo developmental patterns, the two genes appear to be independently regulated. In lung samples of 21-22 wk the correlation between levels of SP-B and SP-C mRNAs was no stronger than the correlation with an mRNA (Gso) that is unrelated to pulmonary surfactant and is not influenced by glucocorticoids.
We studied tissue distribution of the surfactant protein mRNAs in a variety of dog tissues. SP-B mRNA was detected only in lung tissue. Results were the same for SP-C mRNA except for a low level of hybridizable mRNA in adult but not newborn spleen. The hybridization observed in adult spleen most likely reflects the presence of an mRNA similar to SP-C mRNA. These data suggest that the hydrophobic surfactant proteins are expressed only in lung tissue.
Explant culture has been a useful approach to investigating regulation of surfactant components. When fetal tissue is cultured in the absence of serum or hormones, changes occur that are consistent with differentiation of type II cells (reviewed in reference 13). It has been proposed that this process reflects precocious lung maturation, perhaps secondary to removal of more rapid than for SP-C mRNA, and maximal levels in treated cultures occurred after 2 and 6 d of culture, respectively (e.g., Fig. 5 ). Induction of both mRNAs was reversible; sustained stimulation required the continuous presence of glucocorticoid. The different kinetics for induction and deinduction of SP-B and SP-C mRNAs could be due to differences in the mechanism of glucocorticoid action and/or mRNA stability. Additional studies will be required to determine whether the genes are directly activated by glucocorticoid-receptor complex or whether induction is mediated by other glucocorticoid-induced proteins. Induction of both mRNAs also occurred with natural corticosteroids. By contrast, sex steroids had no effect. We found similar results in earlier studies with human lung examining the rate of choline incorporation into phosphatidylcholine (24). The stimulatory effect ofcortisone, which has no intrinsic glucocorticoid activity, was not unexpected, since lung tissue contains 1 lj3-hydroxysteroid dehydrogenase which catalyzes interconversion of cortisone and cortisol (29, 31) .
Dose-response patterns to glucocorticoid were different for the two mRNAs. Half-maximal stimulation with dexamethasone occurred at approximately fivefold lower concentrations for SP-B mRNA than for SP-C mRNA. The dose-response pattern for SP-B mRNA is similar to that recently observed for dexamethasone stimulation of fatty acid synthetase activity (half maximal at -2 nM) in human lung explants (32) . Induction of SP-A is also half maximal at 1-2 nM dexamethasone, but stimulation decreases at concentrations > 10 nM (33) . For comparison, the Kd for dexamethasone binding in intact lung cells at 370C is 5-16 nM (34, 35) . The response curves for cortisol indicated half-maximal effects at 300 and 1,000 nM for SP-B and SP-C mRNA, respectively. The decreased potency of cortisol compared with dexamethasone is consistent with its lower binding affinity for receptor and with partial metabolism to cortisone during culture.
The dose-response findings could be accounted for if induction of SP-B mRNA (concentration of dexamethasone for half-maximal stimulation < receptor K) but not SP-C mRNA (for which half-maximal concentration _ Kd) were amplified by induction of other protein(s) that increase gene transcription or mRNA stability. Alternatively, the apparent dose-response differences could arise from differences in the kinetics of response for the two genes.
cAMP has been shown to affect other components of the surfactant system. Synthesis of both phosphatidylcholine (as assessed by choline incorporation) and SP-A are stimulated by cAMP analogues, f,-adrenergic agonists, and other agents that increase intracellular cAMP (forskolin and inhibitors ofcAMP phosphodiesterase) (16, 18, 19, 33, 36) . At doses of terbutaline and forskolin that were optimal for stimulation of SP-A, we found increased levels of SP-B mRNA but not SP-C mRNA. The induction of SP-B mRNA by these agents was less than that seen with dexamethasone, and additive effects were not apparent. Whitsett et al. (20) reported some increase in both SP mRNAs by 8-bromo-cAMP but no apparent effect on content of the proteins as measured by ELISA assay.
We have not examined synthesis of the hydrophobic proteins per se in this study. In the report by Whitsett et al. (20) studies of protein synthesis and processing were carried out with an antiserum that appears to react with both SP-B and SP-C precursors. These workers found that dexamethasone treatment of lung explants increased [35S]methionine incorporation into immunoprecipitable proteins of Mr = 42,000 and 25,000, which presumably represent the precursor proteins for SP-B and SP-C, respectively. Thus, it is likely that the changes in mRNA levels described in the present study also reflect synthesis of both precursor proteins. The type and amount of processing of these proteins in the culture system is not yet defined.
In summary, we have found that expression of the genes for the two hydrophobic surfactant proteins begins during the second trimester of human gestation. Although both mRNAs increase with development, the two genes appear to be independently regulated. During explant culture without serum or hormones the level of SP-B mRNA increases, whereas SP-C mRNA decreases. Both mRNAs are induced by glucocorticoids by processes involving receptors; however, differences in glucocorticoid potency and in the time courses for induction indicate that the responses may involve different mechanisms of pretranslational regulation. The two mRNAs also differ in their response to agents that increase intracellular cAMP.
Glucocorticoid treatment accelerates lung development in fetal animals and reduces the incidence of hyaline membrane disease in premature human infants. Increased production of pulmonary surface active phospholipids is a critical aspect of this response. The results of this and other recent studies suggest that glucocorticoids also simulate synthesis of the three proteins associated with surfactant.
